HER-2阳性乳腺癌分子靶向治疗进展(5)
[10]Gianni L，Pienkowski T，Im YH，et al.Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced，inflammatory，or early HER2-positive breast caneer(NeoSphere)：arandomised multicentre，open-label，phase 2 trial[J].Lancet Oncol，2012，13(1)：25-32.[11]Welslau M，Diéras V ......
您现在查看是摘要页，全文长 2697 字符。